UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported): May 16, 2013 (May 10, 2013)
American Realty Capital Healthcare Trust II, Inc.
(Exact Name of Registrant as Specified in Charter)
Maryland | 333-184677 | 38-3888962 | ||
(State or other jurisdiction of incorporation or organization) |
(Commission File Number) |
(I.R.S. Employer Identification No.) | ||
|
405 Park Avenue New York, New York 10022 |
(Address, including zip code, of Principal Executive Offices) Registrant's telephone number, including area code: (212) 415-6500 |
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Item 2.01. Completion of Acquisition or Disposition of Assets.
On May 10, 2013, American Realty Capital Healthcare Trust II, Inc. (the “Company”), through a subsidiary of its operating partnership, closed its acquisition of the fee simple interest in a Fresenius dialysis center located in Winfield, Alabama. The seller of the property was TST Appleton South, LLC, an entity which has no material relationship with the Company, and the acquisition was not an affiliated transaction.
The property contains 5,564 rentable square feet and the tenant provides kidney dialysis services and renal care products for its patients.
The property is 100% leased to Fresenius Medical Care of Northwest Alabama, a subsidiary of Fresenius Medical Care Holdings, Inc., which guarantees the lease. The lease is net whereby the tenant is required to pay substantially all operating expenses, excluding all costs to maintain and repair the roof and structure of the building, in addition to base rent. The lease has an original 15-year term which commenced in March 2008 and expires in February 2023. The lease contains rental escalations of 10% every 5 years and has three renewal options of five years each. The annualized straight-line rental income for the initial term will be $0.2 million or $28.40 per rentable square foot.
The contract purchase price of the property was $1.9 million. The Company funded the acquisition of the property with proceeds from its ongoing public offering.
A copy of the press release announcing the Company’s acquisition of the Fresenius dialysis center is attached to this Current Report on Form 8-K.
Item 9.01. Financial Statements and Exhibits.
(a) | Financial Statements of Business Acquired (Lessees) |
Set forth in this Item 9.01(a) are summary financial statements of the parent of the guarantor of the lease, Fresenius Medical Care AG & Co. KGaA (“Fresenius”), as described under Item 2.01 of this Current Report on Form 8-K. Fresenius currently files its financial statements in reports filed with the SEC, and the following summary financial data regarding Fresenius are taken from such filings:
Three Months Ended | Years Ended | |||||||||||||||
(Amounts in Thousands) | March
31, 2013 | December 31, 2012 | December 31, 2011 | December 31, 2010 | ||||||||||||
Consolidated Condensed Statements of Income | ||||||||||||||||
Net revenue | $ | 3,463,921 | $ | 13,800,282 | $ | 12,570,515 | $ | 11,844,194 | ||||||||
Operating income | 493,313 | 2,218,573 | 2,074,892 | 1,923,805 | ||||||||||||
Net income | 225,499 | 1,186,809 | 1,071,154 | 987,517 |
(Amounts in Thousands) | March
31, 2013 | December 31, 2012 | December 31, 2011 | December 31, 2010 | ||||||||||||
Consolidated Condensed Balance Sheets | ||||||||||||||||
Total assets | $ | 22,139,663 | $ | 22,325,998 | $ | 19,532,850 | $ | 17,094,661 | ||||||||
Long-term debt and capital lease obligations | 7,360,613 | 7,841,914 | 5,494,810 | 4,309,676 | ||||||||||||
Total liabilities | 12,244,196 | 12,595,478 | 11,061,342 | 9,291,041 | ||||||||||||
Total shareholders | 9,344,065 | 9,207,260 | 8,061,017 | 7,523,911” |
(d) | Exhibits |
Exhibit No. | Description | |
99.1 | Press Release dated May 16, 2013 |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
AMERICAN REALTY CAPITAL HEALTHCARE TRUST II, INC. | |||
Date: May 16, 2013 |
By: |
/s/ Thomas P. D’Arcy |
|
Thomas P. D’Arcy | |||
Chief Executive Officer |
CONTACTS
From: Anthony J. DeFazio | For: Brian S. Block, EVP & CFO |
Diccicco Battista Communications | American Realty Capital Healthcare Trust II, Inc. |
tdefazio@ddcworks.com | bblock@arlcap.com |
Ph: (484-342-3600) | Ph: (212-415-6500) |
FOR IMMEDIATE RELEASE
American Realty Capital Healthcare Trust II Makes First Acquisition
New York, New York, May 16, 2013 ˗ American Realty Capital Healthcare Trust II, Inc. (“ARC HT II”) announced today that it closed on its first acquisition – a Fresenius dialysis center located in Winfield, Alabama. The purchase price of the property was $1.9 million, exclusive of closing costs.
The Fresenius dialysis center contain 5,564 rentable square feet and is net leased to a subsidiary of Fresenius Medical Care Holdings, Inc., which guarantees the lease. The guarantor is a subsidiary of Fresenius Medical Care AG & Co. KGaA (“Fresenius”).
Fresenius is a German-based holding and kidney dialysis company, operating in the fields of dialysis products and dialysis services. Its dialysis business is vertically integrated, providing dialysis treatment at its own dialysis clinics and supplying these clinics with a range of products. In addition, the tenant sells dialysis products to other dialysis service providers. The tenant operates in North America and internationally.
Important Notice
ARC HT II is a publicly registered, non-traded real estate investment trust (“REIT”) that intends to qualify as a REIT for tax purposes with the taxable year ending December 31, 2013.
The statements in this press release that are not historical facts may be forward-looking statements. These forward-looking statements involve risks and uncertainties that could cause the outcome to be materially different. In addition, words such as “anticipate,” “believe,” “expect” and “intend” indicate a forward-looking statement, although not all forward-looking statements include these words.
For more information about this announcement, please contact Tony DeFazio at 484-342-3600 or tdefazio@ddcworks.com.